-
Wisselink MA, Willemse T. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study. Vet J. 2009;180(1):55-59.
-
Roberts ES, Vanlare KA, Strehlau G, Peyrou M, Roycroft LM, King S. Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats) in cats. J Vet Pharmacol Ther. 2014;37(2):161-168.
-
Palmeiro BS. Cyclosporine in veterinary dermatology. Vet Clin North Am Small Anim Pract. 2013;43(2):153-171.
-
Nuttall T, Reece D, Roberts E. Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis. Vet Rec. 2014;174 (Suppl 2):3-12.
-
Guaguère E, Steffan J, Olivry T. Cyclosporin A: a new drug in the field of canine dermatology. Vet Dermatol. 2004; 15(2):61-74.
-
Kovalik M, Thoday KL, van den Broek AH. The use of ciclosporin A in veterinary dermatology. Vet J. 2012;193(2): 317-325.
-
Forsythe P, Paterson S. Ciclosporin 10 years on: indications and efficacy. Vet Rec. 2004;174(Suppl 2):13-21.
-
Gonzales AJ, Bowman JW, Fici GJ, Zhang M, Mann DW, Mitton-Fry M. Oclacitinib (APOQUEL) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther. 2014;37(4):317-324.
-
Plumb DC. Cyclosporine (systemic). In: Plumb DC, ed. Plumb’s Veterinary Drug Handbook. 8th ed. Ames, IA: Wiley-Blackwell; 2015:364-369.
-
Atopica for Cats (product insert), Atopica for Dogs (product insert). Greensboro, NC; Novartis Animal Health; 2008.
-
Ho S, Clipstone N, Timmerman L, et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol. 1996;80(3 Pt 2):S40-S45.
-
Steffan J, Alexander D, Brovedani F, Fisch RD. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial. Vet Dermatol. 2003;14(1):11-22.
-
Barrs VR, Martin P, Beatty JA. Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy. Aust Vet J. 2006;84(1-2):30-35.
-
Last R D, Suzuki Y, Manning T, Lindsay D, Galipeau L, Whitbread TJ. A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin A for feline atopy. Vet Dermatol. 2004;15(3):194-198.
-
Beatty J, Barrs V. Acute toxoplasmosis in two cats on cyclosporine therapy. Aust Vet J. 2008;81(6):339.
-
Griffin A, Newton AL, Aronson LR, Brown DC, Hess RS. Disseminated Mycobacterium avium complex infection following renal transplantation in a cat. JAVMA. 2003;222(8):1097-1101.
-
Swift IM, Griffin A, Shipstone MA. Successful treatment of disseminated cutaneous phaeohyphomycosis in a dog. Aust Vet J. 2006;84(12):431-435.
-
Werner AH. Psoriasiform-lichenoid-like dermatosis in three dogs treated with microemulsified cyclosporine A. JAVMA. 2003;223(7):1013-1016.
-
Stefan J, King S, Seewald W, et al. Ciclosporin efficacy in the treatment of feline hypersensitivity dermatitis is not influenced by the feeding status (abstract from 2012 World Congress). Vet Dermatol. 2012;23(Suppl 1):64.
-
Apoquel (product insert). Kalamazoo, MI; Zoetis; 2013.
-
Olivry T, Bizikova P. A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update. Vet Dermatol. 2013;24(1):97-117, e25-26.
-
Olivry T, Foster AP, Mueller RS, McEwan NA, Chesney C, Williams HC. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol. 2010;21(1):4-22.
-
Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479-e114.
-
Cosgrove SB, Wren JA, Cleaver DM, et al. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel) in client-owned dogs with atopic dermatitis. Vet Dermatol. 2013; 24(6):587-597, e141-142.
-
Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015;26(3):171-179, e35.